Nektar Therapeutics (NKTR) ownership: Top institutional holder: FMR LLC ($309.61M). Insider activity: Net Seller (0 buys, 20 sells). SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| FMR LLC | 4303188.00 | $309.61M | 2026-03-31 |
| BVF INC/IL | 2559595.00 | $184.16M | 2026-03-31 |
| BlackRock Fund Advisors | 13843692.00 | $169.86M | 2016-12-31 |
| Two Seas Capital LP | 1959178.00 | $140.96M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 1197055.00 | $86.13M | 2026-03-31 |
| TWO SIGMA INVESTMENTS, LP | 930741.00 | $66.97M | 2026-03-31 |
| Prosight Management, LP | 735000.00 | $52.88M | 2026-03-31 |
| BlackRock, Inc. | 692650.00 | $49.84M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-15 | |
| Sell | null | 2026-05-19 | |
| Sell | null | 2026-05-19 | |
| Sell | null | 2026-05-19 | |
| Sell | null | 2026-05-19 | |
| Sell | null | 2026-02-18 | |
| Sell | null | 2026-02-18 | |
| Sell | null | 2026-02-18 |
Back to NKTR overview · NKTR earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.